These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31909571)

  • 1. Preoperative predictors of early relapse/no-remission of type-2 diabetes after metabolic surgery in Chinese patients.
    Nautiyal HK; Guan W; Lin S; Liang H
    Clin Obes; 2020 Apr; 10(2):e12350. PubMed ID: 31909571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.
    Huang CK; Tai CM; Chang PC; Malapan K; Tsai CC; Yolsuriyanwong K
    Obes Surg; 2016 Oct; 26(10):2291-301. PubMed ID: 26935711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Chinese T2D patients with BMI 20-32.5 kg/m
    Lin S; Yang N; Guan W; Liang H
    Surg Obes Relat Dis; 2019 Sep; 15(9):1513-1519. PubMed ID: 31548005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.
    Moradi M; Kabir A; Khalili D; Lakeh MM; Dodaran MS; Pazouki A; Kermansaravi M; Alibeigi P; Moazenzadeh H; Abdolhosseini MR; Eghbali F; Baradaran HR
    BMC Endocr Disord; 2022 Oct; 22(1):260. PubMed ID: 36289529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2.
    Yu H; Di J; Bao Y; Zhang P; Zhang L; Tu Y; Han X; Jia W
    Surg Obes Relat Dis; 2015; 11(1):6-11. PubMed ID: 25547054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
    Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
    Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Different Procedures of Metabolic Surgery for Type 2 Diabetes in Asia: a Multinational and Multicenter Exploratory Study.
    Shen SC; Lee WJ; Kasama K; Seki Y; Su YH; Wong SK; Huang YM; Wang W
    Obes Surg; 2021 May; 31(5):2153-2160. PubMed ID: 33523416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes.
    Feng W; Yin T; Chu X; Shan X; Jiang C; Wang Y; Qian Y; Zhu D; Sun X; Bi Y
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3138. PubMed ID: 30740871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m
    Chong K; Ikramuddin S; Lee WJ; Billington CJ; Bantle JP; Wang Q; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Korner J; Chuang LM
    Obes Surg; 2017 May; 27(5):1189-1195. PubMed ID: 27783367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
    Moriconi D; Manca ML; Anselmino M; Rebelos E; Bellini R; Taddei S; Ferrannini E; Nannipieri M
    Diabetes Metab; 2022 Jan; 48(1):101282. PubMed ID: 34547450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect and Predictive Score of Gastric Bypass and Sleeve Gastrectomy on Type 2 Diabetes Mellitus Patients with BMI < 30 kg/m(2).
    Lee WJ; Almulaifi A; Chong K; Chen SC; Tsou JJ; Ser KH; Lee YC; Chen JC
    Obes Surg; 2015 Oct; 25(10):1772-8. PubMed ID: 25676157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Roux-en Y Gastric Bypass Versus Vertical Sleeve Gastrectomy for Sustained Remission of Type 2 Diabetes Mellitus.
    Nudotor RD; Prokopowicz G; Abbey EJ; Gonzalez A; Canner JK; Steele KE
    J Surg Res; 2021 May; 261():407-416. PubMed ID: 33515868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.
    Musella M; Apers J; Rheinwalt K; Ribeiro R; Manno E; Greco F; Čierny M; Milone M; Di Stefano C; Guler S; Van Lessen IM; Guerra A; Maglio MN; Bonfanti R; Novotna R; Coretti G; Piazza L
    Obes Surg; 2016 May; 26(5):933-40. PubMed ID: 26341086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-2 diabetes mellitus remission prediction models after Roux-En-Y gastric bypass and sleeve gastrectomy based on disease severity scores.
    Ghusn W; Hage K; Vierkant RA; Collazo-Clavell ML; Abu Dayyeh BK; Kellogg TA; Acosta A; Ghanem OM
    Diabetes Res Clin Pract; 2024 Feb; 208():111091. PubMed ID: 38224874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Fasting C-Peptide Predicts Type 2 Diabetes Mellitus Remission in Low-BMI Chinese Patients After Roux-en-Y Gastric Bypass.
    Zhao L; Li W; Su Z; Liu Y; Zhu L; Zhu S
    J Gastrointest Surg; 2018 Oct; 22(10):1672-1678. PubMed ID: 29845572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.
    McTigue KM; Wellman R; Nauman E; Anau J; Coley RY; Odor A; Tice J; Coleman KJ; Courcoulas A; Pardee RE; Toh S; Janning CD; Williams N; Cook A; Sturtevant JL; Horgan C; Arterburn D;
    JAMA Surg; 2020 May; 155(5):e200087. PubMed ID: 32129809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued Diabetes Remission Despite Weight Recurrence: Gastric Bypass Long-Term Metabolic Benefit.
    Ghanem OM; Abi Mosleh K; Kerbage A; Lu L; Hage K; Abu Dayyeh BK
    J Am Coll Surg; 2024 May; 238(5):862-871. PubMed ID: 38349010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study.
    Lee WJ; Hur KY; Lakadawala M; Kasama K; Wong SK; Lee YC
    J Gastrointest Surg; 2012 Jan; 16(1):45-51; discussion 51-2. PubMed ID: 22042564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide level as predictor of type 2 diabetes remission and body composition changes in non-diabetic and diabetic patients after Roux-en-Y gastric bypass.
    de Cleva R; Kawamoto F; Borges G; Caproni P; Cassenote AJF; Santo MA
    Clinics (Sao Paulo); 2021; 76():e2906. PubMed ID: 34378729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting relapse of type 2 diabetes after bariatric surgery in Sweden 2007-2015: a registry-based cohort study.
    Jans A; Szabo E; Näslund I; Ottosson J; Näslund E; Stenberg E
    Surg Obes Relat Dis; 2022 Mar; 18(3):305-312. PubMed ID: 34974997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.